Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
After the completion of the study, it was noted that there appeared to be a significant reduction in the body weight of these murine models, including a reduction of excess body lipids
Good customer service I have not seen any difference in my moods or energy level I have been using for three weeks I have not noticed a difference with appetite control
Cost trajectory: Months 1-3 (1-2.5 mg): $250-$350/month
no refrigeration needed Retatrutide (triple-agonist GLP-1, GIP, glucagon) Status: Currently in Phase II/III trials Average weight loss: 17.524% in initial studies Notable facts: Promising triple-targeting mechanism for substantial weight reduction Mazdutide (IBI-362) Status: Approved in China as of June 2025
I am eating half of what I did
J., Webb, D
US$ 24.18
US$ 24.46
US$ 20.39
US$ 25.71
